← Stock Trading Canary · All insider profiles
INSIDER PROFILE · SE
Curt Mikael von Euler-Chelpin
Annan medlem i bolagets administrations-, lednings- eller kontrollorgan | Styrelseledamot
Profile key: se|curt mikael von euler-chelpin
Purchase history
- Companies traded
- 5
- Purchases · 12M
- 8
- Purchases · 24M
- 8
- Average purchase
- SEK 42,880
- Gross purchase value
- SEK 343,040
- Last purchase
- 2026-07-09
- Completed 20D events
- 6.0
- Outcome status
- PASS
Latest company: Annexin Pharmaceuticals AB (publ)
Companies: Annexin Pharmaceuticals AB (publ) | Dicot Pharma | Dicot Pharma AB | Spago Nanomedical AB (publ) | XSpray Pharma AB (publ)
Post-purchase outcomes
Benchmark-relative outcomes are available against OMX Stockholm 30.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 6Developing | 100.0% (6/6) | 16.7% (1/6) | -5.4% | -5.5% | -19.8% |
| 20D | 6Developing | 100.0% (6/6) | 16.7% (1/6) | -6.5% | -10.2% | -25.3% |
| 60D | 6Developing | 100.0% (6/6) | 16.7% (1/6) | -21.5% | -19.4% | -44.0% |
| 120D | 2Small sample | 100.0% (2/2) | 50.0% (1/2) | -14.3% | -14.3% | -48.5% |
Research patterns
- First purchase in 12M
- 6/6
- Large purchase ≥ €100k
- 0/6
- Cluster buying · 15D
- 2/6
- Buying the dip · ≥20% below prior 52W high
- 6/6
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.